skip to page content

United States Department of Veterans Affairs

United States Department of Veterans Affairs

National HIV/AIDS Program

	Providers' Home > News > ARV Alerts	Enlarge Text Size:

News

ARV Alerts

ARV Alerts contain breaking information on antiretroviral drug interactions and adverse effects.

10/23/08: Darunavir Approved for QD Dosing in Naive Patients
8/29/08: Changes to Ritonavir (Norvir) Product Label
8/21/08: Changes to Atazanavir (Reyataz) Package Insert
7/25/08: HLA-B*5701 Testing in Abacavir Patients
7/9/08: Changes to Nevirapine Product Labeling
4/4/08: Commentary on the Use of Abacavir or Didanosine and Higher Risk of Heart Attack
3/12/08: Addition of Warning on Heptotoxicity to Prescribing Information for Prezista (Darunavir) Tablets
FDA Safety Alerts
3/12/08: Risk of Peripheral Neuropathy in Patients Treated with Telbivudine (Sebivo) in Combination with Interferon
Public Communication from Health Canada
12/14/07: Updated Information Regarding Antiretroviral Agents Used as HIV Postexposure Prophylaxis for Occupational HIV Exposures
MMRW 56(49);1291-1292
10/05/07: Nelfinavir (marketed as Viracept) Impurity and Potential Shortage Information


			Print this page

			Email this page

See also

OPHEH | Environmental Agents | Emergency Management | Public Health
Occupational Health | Women's Health | Environmental Epidemiology

Reviewed/Updated Date: October 27, 2008